Provided by Tiger Fintech (Singapore) Pte. Ltd.

PIMCO Municipal Income Fund II

7.39
+0.05000.68%
Post-market: 7.390.00000.00%16:04 EDT
Volume:347.62K
Turnover:2.57M
Market Cap:491.14M
PE:-138.34
High:7.42
Open:7.38
Low:7.35
Close:7.34
Loading ...

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

GlobeNewswire
·
02 May

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswire
·
10 Apr

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

GlobeNewswire
·
07 Apr

PIMCO Closed-End Funds Announce Proposed Reorganizations

GlobeNewswire
·
05 Apr

UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE

PR Newswire
·
04 Apr

UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS

PR Newswire
·
13 Mar

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswire
·
07 Mar

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

GlobeNewswire
·
04 Mar

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

GlobeNewswire
·
27 Feb

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

GlobeNewswire
·
04 Feb

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma

Business Wire
·
17 Jan

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

GlobeNewswire
·
03 Jan